Outcomes after switching from one anti-tumor necrosis factor α agent to a second anti-tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a Large UK National Cohort Study

Kimme L. Hyrich, Mark Lunt, Kath D. Watson, Deborah P M Symmons, Alan J. Silman

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article › peer-review

1 results

British Society for Rheumatology Rheumatoid Arthritis Register (BSRBR-RA)
Hyrich, K. (PI), Watson, K. (Support team), Mowbray, K. (Support team), Kearsley-Fleet, L. (CoI), Lunt, M. (CoI) & Verstappen, S. (CoI)
Project: Research